Aptus Capital Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$278K Sell
5,118
-832
-14% -$40.5K ﹤0.01% 979
2026
Q1
$255K Sell
5,950
-383
-6% -$16.5K ﹤0.01% 930
2025
Q4
$278K Buy
+6,333
New +$262K ﹤0.01% 913

Other funds holding EXEL

Aptus Capital Advisors's EXEL Position: Q2 2026 in Review

Aptus Capital Advisors reduced its Exelixis (EXEL) stake by 14% in Q2 2026, selling an estimated $40.5K and leaving 5,118 shares worth $278K. The position accounts for ﹤0.01% of the portfolio, ranked #979.

Aptus Capital Advisors first reported a position in EXEL in Q4 2025 and has held it in 3 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Aptus Capital Advisors held 5,118 shares of Exelixis worth $278K as of Q2 2026.
  • Aptus Capital Advisors sold 832 Exelixis shares in Q2 2026, an estimated $40.5K.
  • Exelixis made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #979 holding.
  • Aptus Capital Advisors first reported a position in Exelixis in Q4 2025 and has held it in 3 quarters since.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.